Maggie Cam

3.2k total citations
37 papers, 1.1k citations indexed

About

Maggie Cam is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Maggie Cam has authored 37 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 14 papers in Oncology and 12 papers in Epidemiology. Recurrent topics in Maggie Cam's work include Cancer-related molecular mechanisms research (5 papers), Cervical Cancer and HPV Research (5 papers) and Cancer Genomics and Diagnostics (4 papers). Maggie Cam is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), Cervical Cancer and HPV Research (5 papers) and Cancer Genomics and Diagnostics (4 papers). Maggie Cam collaborates with scholars based in United States, China and United Kingdom. Maggie Cam's co-authors include Zhi‐Ming Zheng, Ying Huang, Michael Fried, Dickens Theodore, Steven Zacks, Santosh Kumar Nanda, Susan N. Pusek, Jake T. Liang, Weiping Chen and Jordan J. Feld and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Maggie Cam

34 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maggie Cam United States 18 395 349 287 239 225 37 1.1k
Yasuhiro Nakayama Japan 19 382 1.0× 291 0.8× 166 0.6× 276 1.2× 234 1.0× 60 1.0k
Francesca De Nicola Italy 18 666 1.7× 402 1.2× 236 0.8× 151 0.6× 227 1.0× 39 1.1k
Andrea L. George United States 12 382 1.0× 107 0.3× 172 0.6× 230 1.0× 56 0.2× 27 766
Naoki Ikeda Japan 17 332 0.8× 174 0.5× 194 0.7× 234 1.0× 54 0.2× 66 942
Anthony J. Scarzello United States 14 264 0.7× 184 0.5× 296 1.0× 456 1.9× 125 0.6× 16 886
Cheng‐Po Hu Taiwan 16 283 0.7× 217 0.6× 182 0.6× 136 0.6× 148 0.7× 27 699
Bruno Dumont France 15 378 1.0× 230 0.7× 134 0.5× 91 0.4× 131 0.6× 20 834
Michael Hahne France 11 652 1.7× 260 0.7× 232 0.8× 1.1k 4.4× 102 0.5× 12 1.7k
Jessica Fioravanti Spain 15 209 0.5× 197 0.6× 400 1.4× 559 2.3× 137 0.6× 22 998
Ahmed Lasfar United States 19 324 0.8× 165 0.5× 368 1.3× 433 1.8× 131 0.6× 30 981

Countries citing papers authored by Maggie Cam

Since Specialization
Citations

This map shows the geographic impact of Maggie Cam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maggie Cam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maggie Cam more than expected).

Fields of papers citing papers by Maggie Cam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maggie Cam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maggie Cam. The network helps show where Maggie Cam may publish in the future.

Co-authorship network of co-authors of Maggie Cam

This figure shows the co-authorship network connecting the top 25 collaborators of Maggie Cam. A scholar is included among the top collaborators of Maggie Cam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maggie Cam. Maggie Cam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Greer, Yoshimi Endo, Alexei Lobanov, Lisa A. Ridnour, et al.. (2025). TRAIL induces cytokine production via the NFkB2 pathway promoting neutrophil chemotaxis and neutrophil-mediated immune-suppression in triple negative breast cancer cells. Cancer Letters. 620. 217692–217692. 2 indexed citations
2.
Alam, Muhammad S., Matthias M. Gaida, Hagen Roland Witzel, et al.. (2024). TNFR1 signaling promotes pancreatic tumor growth by limiting dendritic cell number and function. Cell Reports Medicine. 5(9). 101696–101696. 11 indexed citations
3.
Monge, Cecilia, Changqing Xie, Yuta Myojin, et al.. (2024). Combined immune checkpoint inhibition with durvalumab and tremelimumab with and without radiofrequency ablation in patients with advanced biliary tract carcinoma. Cancer Medicine. 13(3). e6912–e6912. 6 indexed citations
4.
So, Jae Young, Abdul Ahad, Noémi Kedei, et al.. (2024). Loss of tumor suppressors promotes inflammatory tumor microenvironment and enhances LAG3+T cell mediated immune suppression. Nature Communications. 15(1). 5873–5873. 8 indexed citations
5.
6.
Monge, Cecilia, Changqing Xie, Yuta Myojin, et al.. (2023). Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancer. Journal for ImmunoTherapy of Cancer. 11(2). e005640–e005640. 46 indexed citations
7.
Wang, Xin, Jianyang Fu, Michael C. Kelly, et al.. (2023). Single-cell RNA sequencing reveals cancer stem-like cells and dynamics in tumor microenvironment during cholangiocarcinoma progression. Frontiers in Cell and Developmental Biology. 11. 1250215–1250215. 3 indexed citations
8.
Lam, Norris, Richard Finney, Shicheng Yang, et al.. (2023). Development of a bicistronic anti-CD19/CD20 CAR construct including abrogation of unexpected nucleic acid sequence deletions. Molecular Therapy — Oncolytics. 30. 132–149. 9 indexed citations
9.
Fu, Jianyang, Xin Wang, Jihye Lee, et al.. (2022). Characterization of Immunogenicity of Malignant Cells with Stemness in Intrahepatic Cholangiocarcinoma by Single-Cell RNA Sequencing. Stem Cells International. 2022. 1–14. 12 indexed citations
10.
Ohigashi, Izumi, Sayumi Fujimori, Naozumi Ishimaru, et al.. (2021). The thymoproteasome hardwires the TCR repertoire of CD8+ T cells in the cortex independent of negative selection. The Journal of Experimental Medicine. 218(4). 14 indexed citations
11.
Tighe, Anthony, Darawalee Wangsa, Dali Zong, et al.. (2021). TP53 loss initiates chromosomal instability in fallopian tube epithelial cells. Disease Models & Mechanisms. 14(11). 15 indexed citations
12.
Yu, Lulu, Vladimır Majerčiak, Xiangyang Xue, et al.. (2021). Mouse papillomavirus type 1 (MmuPV1) DNA is frequently integrated in benign tumors by microhomology-mediated end-joining. PLoS Pathogens. 17(8). e1009812–e1009812. 19 indexed citations
13.
Cowan, Jennifer E., Justin Malin, Yongge Zhao, et al.. (2019). Myc controls a distinct transcriptional program in fetal thymic epithelial cells that determines thymus growth. Nature Communications. 10(1). 5498–5498. 44 indexed citations
14.
Medina, Scott H., et al.. (2019). Identification of a mechanogenetic link between substrate stiffness and chemotherapeutic response in breast cancer. Biomaterials. 202. 1–11. 51 indexed citations
16.
Nath, Pulak Ranjan, Arunakumar Gangaplara, Ajeet Mandal, et al.. (2018). CD47 Expression in Natural Killer Cells Regulates Homeostasis and Modulates Immune Response to Lymphocytic Choriomeningitis Virus. Frontiers in Immunology. 9. 2985–2985. 53 indexed citations
17.
Cramer, Sarah D., Julie A. Hixon, Caroline Andrews, et al.. (2018). Mutant IL-7Rα and mutant NRas are sufficient to induce murine T cell acute lymphoblastic leukemia. Leukemia. 32(8). 1795–1882. 11 indexed citations
18.
Puttaraju, M., et al.. (2017). Identification of novel RNA isoforms of LMNA. Nucleus. 8(5). 573–582. 8 indexed citations
19.
Lack, Justin, Marc Gillard, Maggie Cam, Gladell P. Paner, & David James VanderWeele. (2017). Circulating tumor cells capture disease evolution in advanced prostate cancer. Journal of Translational Medicine. 15(1). 44–44. 26 indexed citations
20.
Xue, Xiangyang, Vladimır Majerčiak, Aayushi Uberoi, et al.. (2017). The full transcription map of mouse papillomavirus type 1 (MmuPV1) in mouse wart tissues. PLoS Pathogens. 13(11). e1006715–e1006715. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026